MRM
MEDIROM Healthcare Technologies Inc. Consumer Cyclical - Personal Services Investor Relations →
MEDIROM Healthcare Technologies Inc. (MRM) closed at $1.33 as of 2026-02-02, trading 68.8% below its 200-week moving average of $4.27. This places MRM in the extreme value zone. The stock is currently moving closer to the line, down from -65.6% last week. With a 14-week RSI of 21, MRM is in oversold territory.
Over the past 218 weeks of data, MRM has crossed below its 200-week moving average 1 time. On average, these episodes lasted 218 weeks.
With a market cap of $11 million, MRM is a small-cap stock. The company generates a free cash flow yield of 2973.8%, which is notably high. Return on equity stands at 53.2%, indicating strong profitability. The stock trades at 6.8x book value.
Share count has increased 61.8% over three years, indicating dilution.
Over the past 4.2 years, a hypothetical investment of $100 in MRM would have grown to $22, compared to $154 for the S&P 500. MRM has returned -30.0% annualized vs 10.7% for the index, underperforming the broader market over this period.
Free cash flow has been declining. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.
Growth of $100: MRM vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After MRM Crosses Below the Line?
Across 1 historical episodes, buying MRM when it crossed below its 200-week moving average produced an average return of -25.0% after 12 months (median -25.0%), compared to -18.0% for the S&P 500 over the same periods. After 24 months, the average return was -6.0% vs +3.0% for the index.
Each line shows $100 invested at the moment MRM crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
MRM has crossed below its 200-week MA 1 time
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Dec 2021 | Ongoing | 218+ | 93.6% | Ongoing | -81.5% |
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of Friday close, 2026-02-02